insulin vs glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Medications for Weight Loss:

Zhenqi Liu and former UVA graduate student Nathan Weeldreyer, found about 40% of the weight people lose using brand-name drugs like Wegovy or Zepbound comes from something called fat-free mass, which is everything in your body that is not fat

Results may vary and long term Phase 3 data is still pending

Tirzepatide, marketed as Zepbound for weight management, has shown higher average weight loss than semaglutide in many trial comparisons

Research has also explored how tri-agonist signaling may affect fat distribution and body composition parameters, including visceral adiposity and total fat mass

October 1, 2025: More Ozempic Lawsuits Filed in Federal Court There are now 2,809 lawsuits filed in the Ozempic MDL, marking an increase of more than 130 cases over the last month